Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Login Sign up free
Home Screener Maps Charts News Groups Insider Futures Forex Crypto Portfolio Calendar
Pricing
Market News Market Pulse Stocks News ETF News Crypto News

Tenax Therapeutics, Inc.

Contributing Author

Recent Articles by Tenax Therapeutics, Inc.

Aug-10
Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF TENX -89.77% GlobeNewswire
Jul-31
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update TENX -9.27% GlobeNewswire
Jul-02
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TENX +16.33% TENX +5.17% GlobeNewswire
Jul-02
Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026 TENX +16.33% GlobeNewswire
May-12
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update TENX GlobeNewswire
May-08
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) TENX GlobeNewswire
May-04
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer TENX GlobeNewswire
Apr-22
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer TENX GlobeNewswire
Mar-10
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update TENX +31.67% GlobeNewswire
Mar-03
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference TENX GlobeNewswire
Feb-04
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 TENX GlobeNewswire
Dec-17
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment TENX +5.65% GlobeNewswire
Nov-25
Tenax Therapeutics to Participate in Upcoming Investor Conferences TENX GlobeNewswire
Nov-12
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update TENX GlobeNewswire
Nov-06
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF TENX GlobeNewswire
Nov-03
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference TENX GlobeNewswire
Sep-16
Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF TENX GlobeNewswire
Aug-28
Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025 TENX GlobeNewswire
Aug-13
Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update TENX GlobeNewswire
May-14
Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update TENX GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)